Back to top

Nektar’s Phase 3 Eczema Bet: What Rezpegaldesleukin Could Mean for NKTR Stock

Nektar Therapeutics ($NKTR) announced an update on their ongoing clinical study. Nektar Therapeutics is running a Phase 3 study called “A Phase 3 S...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Nektar Therapeutics (NKTR)